Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts.

about

Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation.

P2860

Q42650241-CC953FDD-5287-4095-B4E5-9FAE8BCB3C88

P2860

Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts.

Item

http://www.wikidata.org/entity/Q36290920

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Intrauterine Bone Marrow Trans ...... Osteomacs but Not Osteoblasts.

@ast

Intrauterine Bone Marrow Trans ...... Osteomacs but Not Osteoblasts.

@en

type

Item

label

Intrauterine Bone Marrow Trans ...... Osteomacs but Not Osteoblasts.

@ast

Intrauterine Bone Marrow Trans ...... Osteomacs but Not Osteoblasts.

@en

prefLabel

Intrauterine Bone Marrow Trans ...... Osteomacs but Not Osteoblasts.

@ast

Intrauterine Bone Marrow Trans ...... Osteomacs but Not Osteoblasts.

@en

P1476

Intrauterine Bone Marrow Trans ...... Osteomacs but Not Osteoblasts

@en

P2093

Jerry K Y Chan

http://www.w3.org/2001/XMLSchema#string

Liza J Raggatt

http://www.w3.org/2001/XMLSchema#string

Rebecca Ellis

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonate therapy for osteogenesis imperfecta

Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta.

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta.

Recent advances in osteogenesis imperfecta.

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Cytokine-induced osteopoietic differentiation of transplanted marrow cells.

Evidence for an immune barrier after in utero hematopoietic-cell transplantation.

Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.

In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta.

P304

682-689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEMCR.2015.09.017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kiarash Khosrotehrani

Nicholas M Fisk

Allison R Pettit

Susan Marie Millard

P577

2015-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283493154

http://www.w3.org/2001/XMLSchema#string

P698

26527386

http://www.w3.org/2001/XMLSchema#string

P921

osteogenesis imperfecta

osteoblast

P932

4649292

http://www.w3.org/2001/XMLSchema#string

Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts.

about

P2860

P2860

Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932